Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Clinical Kidney Journal|June 26, 2024
The effect of parathyroid hormone lowering by etelcalcetide therapy on calcification propensity and calciprotein particles in hemodialysis patientsUrsula Thiem, Jakob Lenz, Maria C Haller, et al.
Plos One|February 16, 2017
Cortical porosity not superior to conventional densitometry in identifying hemodialysis patients with fragility fractureBernhard Bielesz, Janina M Patsch, Lukas Fischer, et al.
Cancer Biology & Therapy|August 19, 2008
Everolimus (RAD001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivoDaniel Cejka, Matthias Preusser, Adelheid Woehrer, et al.
Frontiers in Medicine|September 23, 2021
Effect of Oral Sodium Bicarbonate Treatment on 24-Hour Ambulatory Blood Pressure Measurements in Patients With Chronic Kidney Disease and Metabolic AcidosisMartina Gaggl, Alexandra Repitz, Sonja Riesenhuber, et al.
Clinical Kidney Journal|September 12, 2025
Effect of dialysate bicarbonate on calciprotein particle crystallization time (T50) in hemodialysis patients-the D-Bic studyJennifer Machacek, Peter S Neufeld, Andreas Pasch, et al.
Cancer Biology & Therapy|September 14, 2006
Mcl-1 is a relevant molecular target for antisense oligonucleotide strategies in gastric cancer cellsVolker Wacheck, Daniel Cejka, Wolfgang Sieghart, et al.
Clinical Kidney Journal|January 12, 2024
Klotho: a potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease-a comprehensive review from the ERA CKD-MBD working groupMehmet Kanbay, Sidar Copur, Lasin Ozbek, et al.
Cancer Biology & Therapy|April 21, 2010
Effects of vatalanib on tumor growth can be potentiated by mTOR blockade in vivoAgnes Jaeger-Lansky, Daniel Cejka, Liu Ying, et al.
Wiener Medizinische Wochenschrift (1946)|December 21, 2022
[Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)]Daniel Cejka, Robert Wakolbinger-Habel, Emanuel Zitt, et al.
Clinical Kidney Journal|April 23, 2026
Protocadherin FAT1-associated membranous nephropathy after hematopoietic stem cell transplantation-a cohort study with clinico-pathological correlationsMaja C Nackenhorst, Daniela Milovanovic, Alice Schmidt, et al.
Pageof 7